Luminor Medical Technologies Video News Alert from InvestmentPitch Media

Luminor Medical Technologies (TSXV:LMT) recently announced that it has started trading on the Canadian Securities Exchange.  InvestmentPitch Media has produced a “video news alert” that focused on this recent news, combined with an overview of the company.
The company has taken this step as a result of their recent acquisition of Jamaica-Blue Ltd, which has an exclusive Canadian license for all commercial products developed by Rise Research Inc.
“J-BLU’s technological platform promises to create a wide variety of precise formulations that produce specifically-targeted effects for various types of patients, including people with diabetes,” said Luminor Medical CEO Christian Sauvageau. “Patients and healthcare providers expect consistent high quality product produced by the best available practices and methods and that is just what J-BLU provides. Although our primary interest is directed toward the J-BLU diabetes formulation, Luminor Medical will capitalise on every formulation developed for the Canadian and Jamaican markets.”
To see the full video, click here.
Click here to connect with Luminor Medical Technologies (TSXV:LMT) for an Investor Presentation